Form 4 for BCYC BICYCLE THERAPEUTICS PLC
Accepted 2021-12-22 00:00:00 ET · period of report 2021-12-20 · accession 0001209191-21-071007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-22 | 2021-12-20+ | BCYC | Legault Pierre | Dir | M - OptEx | $8.46 | +150.0K | 7,603 | New | +$1.27M |
| DM | 2021-12-22 | 2021-12-20+ | BCYC | Legault Pierre | Dir | S - Sale+OE | $57.69 | -150.0K | 0 | -100% | -$8.65M |
| DM | 2021-12-22 | 2021-12-20+ | BCYC | Legault Pierre | Dir | M - OptEx | $0.00 | -150.0K | 121.2K | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-12-21 | M | A | 44,537 | $8.44 | 44,537 | D | — | — | (F4) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.324735 to GBP 1.00 as of December 21, 2021. |
| 2 | Common | Ordinary Shares | 2021-12-21 | S | D | 44,537 | $57.11 | 0 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.02 to $57.55 inclusive. |
| 3 | Common | Ordinary Shares | 2021-12-20 | S | D | 7,603 | $57.02 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5) and (7). |
| 4 | Common | Ordinary Shares | 2021-12-22 | S | D | 97,860 | $58.01 | 0 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.51 to $58.50 inclusive. |
| 5 | Common | Ordinary Shares | 2021-12-22 | M | A | 97,860 | $8.48 | 97,860 | D | — | — | (F6) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.331495 to GBP 1.00 as of December 22, 2021. |
| 6 | Common | Ordinary Shares | 2021-12-20 | M | A | 7,603 | $8.41 | 7,603 | D | — | — | (F1) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.319915 to GBP 1.00 as of December 20, 2021. |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-12-20 | M | D | 7,603 | $0.00 | 165,709 | D | $8.41 · — to 2029-04-25 | 7,603 Ordinary Shares | (F1) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.319915 to GBP 1.00 as of December 20, 2021. (F8) This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | M | D | 97,860 | $0.00 | 23,312 | D | $8.48 · — to 2029-04-25 | 97,860 Ordinary Shares | (F6) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.331495 to GBP 1.00 as of December 22, 2021. (F8) This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022. |
| 9 | Derivative | Stock Option (Right to Buy) | 2021-12-21 | M | D | 44,537 | $0.00 | 121,172 | D | $8.44 · — to 2029-04-25 | 44,537 Ordinary Shares | (F4) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.324735 to GBP 1.00 as of December 21, 2021. (F8) This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022. |